Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

By R. Cervera, J. Piette, J. Font, M. Khamashta, Y. Shoenfeld, M. Camps, S. Jacobsen, G. Lakos, A. Tincani, I. Kontopoulou-Griva and 18 more. Arthritis & Rheumatism, 2002

2,061 citations recorded by the source corpus.

Subfields: Neurology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/fd944e9d069d44b722abf8df158b3fd88bf68386

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Tektonidou
2. J. Auch
3. M. Zeher
4. T. Tarr
5. G. Pons-Estel
6. R. Cervera
7. G. Theodossiades
8. L. Ceberio-Hualde

Citations in the corpus

• Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009, background): “To describe the course of the disease in patients with APS, we started in 1999 a multicentre observational study of 1000 European patients with a mean age of 42 years. The clinical and immunological characteristics of these patients when entered in the study have been previously reported.”
• The antiphospholipid syndrome. (2002, background): “In APS, virtually any organ can be involved (2, 10) (Table 2) , and the range of disorders spans a diverse spectrum.”